Data-Driven Prior Distributions for A Bayesian Phase-2 COPD Dose-Finding Clinical Trial
Authors:
- 3 July 2018
- journal article
- research article
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 10 (3) , 166-175
Abstract
The prior distribution reflects knowledge and uncertainty of the modeled parameters. Determining the prior distribution for a dose-finding clinical trial can be influential in its design and analysis. Using the planning of a phase 2 trial for COPD with a dose-response curve as a case study, we illustrate the use of relevant historical data for the nonlinear curve mean-model parameters as well as consideration for terms to characterize between-trial and within-trial variability. Through a predictive inference exercise, a data-driven informative prior distribution is constructed for the future study. We share our strategies on how to obtain informative Bayesian priors for both design and analysis of dose-finding clinical trials using relevant historical data and deal with the associated issues.Keywords
Funding Information
- GlaxoSmithKline (NCT02570165)
This publication has 22 references indexed in Scilit:
- Bayesian heavy-tailed models and conflict resolution: A reviewBrazilian Journal of Probability and Statistics, 2012
- Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic ReviewsInternational Journal of Epidemiology, 2012
- A case study of model‐based Bayesian dose response estimationStatistics in Medicine, 2011
- Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical TrialsBiometrics, 2011
- Determining the Effective Sample Size of a Parametric PriorBiometrics, 2008
- Practical Bayesian Design and Analysis for Drug and Device Clinical TrialsJournal of Biopharmaceutical Statistics, 2007
- A Bayesian Design and Analysis for Dose-Response Using Informative Prior InformationJournal of Biopharmaceutical Statistics, 2006
- Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper)Bayesian Analysis, 2006
- Assessment of futility in clinical trialsPharmaceutical Statistics, 2006
- Assurance in clinical trial designPharmaceutical Statistics, 2005